NR3C1 and triple-negative breast carcinoma: Here, Chen et al. show that genes regulated by dexamethasone- but not Compound A-liganded glucocorticoid receptor are associated with therapy resistance and unfavourable clinical outcomes in triple-negative breast cancer.